Verkazia Emulsion
Product Images NDC 65086-001

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Verkazia (NDC 65086-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Santen Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp 120 Carton

Packaging label for Verkazia cyclosporine ophthalmic emulsion 0.1%, sterile topical ophthalmic emulsion. The label shows the product name, active ingredient, strength, and usage instructions. It indicates the package contains 120 single-use 0.3 mL vials. The labeler is Santen Incorporated, with contact information and storage instructions included on a green background panel. The NDC number 65086-001-12 is visible with a barcode.*

FDA Label Image

Pdp Sample Carton

Box label for Verkazia cyclosporine ophthalmic emulsion 0.1%. The label states it is sterile, for topical ophthalmic use, and a professional courtesy package not for sale. It contains 5 single-use 0.3 mL vials. The label includes instructions for use, storage, and manufacturer details, with text on a green and white background and the Santen logo.*

FDA Label Image

Structural Formula (Verkazia 01)

Chemical structure of cyclosporine, the active ingredient in Verkazia 1 mg/mL ophthalmic emulsion by Santen Incorporated, displayed as a detailed molecular formula with atoms and bonds arranged in a cyclic peptide structure.*

FDA Label Image

Table 2 (Verkazia 02)

A data table comparing mean scores with standard deviations over five visits (Baseline through Month 4) for three groups: Vehicle (N=58), Verkazia QID (N=56), and Verkazia BID (N=54). The table includes a 95% Confidence Interval plot for Verkazia QID versus Vehicle, showing effect sizes favoring Verkazia QID with values ranging from -1.1 to -0.7.*

FDA Label Image

Table 3 (Verkazia 03)

A data table comparing vehicle, Verkazia QID, and Verkazia BID groups over visits from baseline through month 4. Values include mean changes with standard deviations, and a graphical 95% confidence interval plot showing differences between Verkazia QID and vehicle, favoring Verkazia QID. The table presents clinical trial outcome data related to Verkazia (cyclosporine) ophthalmic emulsion.*

FDA Label Image

Figure A (Verkazia 04)

Illustration showing two hands holding and twisting open a small tube or vial, likely a single-use container for ophthalmic use. The image visually demonstrates how to open the tube by rotating the top portion for dispensing a dose, consistent with an eye drop emulsion product presentation.*

FDA Label Image

Figure B (Verkazia 05)

An instructional illustration demonstrating the proper technique for instilling an eye drop into the lower eyelid of a patient's eye. The diagram shows a hand holding an eye dropper above an open eye, with the other hand gently pulling down the lower eyelid.*

FDA Label Image

Figure C (Verkazia 06)

An instructional illustration showing a person tilting their head back and pulling down the lower eyelid with a finger, demonstrating how to apply an ophthalmic topical emulsion, likely Verkazia (cyclosporine) 1 mg/mL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.